0001209191-19-035908.txt : 20190610
0001209191-19-035908.hdr.sgml : 20190610
20190610173751
ACCESSION NUMBER: 0001209191-19-035908
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20190601
FILED AS OF DATE: 20190610
DATE AS OF CHANGE: 20190610
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cassidy Meghan
CENTRAL INDEX KEY: 0001775175
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38710
FILM NUMBER: 19889440
MAIL ADDRESS:
STREET 1: C/O CORTEVA, INC.
STREET 2: 974 CENTRE ROAD, BLDG. 735
CITY: WILMINGTON
STATE: DE
ZIP: 19805
FORMER NAME:
FORMER CONFORMED NAME: CASSIDY MEHGAN
DATE OF NAME CHANGE: 20190429
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Corteva, Inc.
CENTRAL INDEX KEY: 0001755672
STANDARD INDUSTRIAL CLASSIFICATION: AGRICULTURE PRODUCTION - CROPS [0100]
IRS NUMBER: 824979096
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 974 CENTRE ROAD
STREET 2: BUILDING 735
CITY: WILMINGTON
STATE: DE
ZIP: 19805
BUSINESS PHONE: (302) 485-3000
MAIL ADDRESS:
STREET 1: 974 CENTRE ROAD
STREET 2: BUILDING 735
CITY: WILMINGTON
STATE: DE
ZIP: 19805
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2019-06-01
0
0001755672
Corteva, Inc.
CTVA
0001775175
Cassidy Meghan
C/O CORTEVA, INC.
974 CENTRE ROAD, CRP 735
WILMINGTON
DE
19805
0
1
0
0
See Remarks
Common Stock
26342.3236
D
Non-Qualified Stock Options
26.76
2026-02-02
Common Stock
19673
D
Non-Qualified Stock Options
34.68
2027-02-01
Common Stock
19792
D
Non-Qualified Stock Options
41.94
2028-02-14
Common Stock
8624
D
On June 1, 2019, the Reporting Person received a dividend of one (1) share of Corteva, Inc. common stock for every three (3) shares of DowDuPont Inc. held by the Reporting Person, and the Reporting Person's equity awards denominated in DowDuPont common stock were adjusted, in part, into equity awards denominated in Corteva common stock, all as described in Corteva's Registration Statement on Form 10 filed with the Securities and Exchange Commission on May 6, 2019. This amount includes restricted stock units and related dividend equivalent units.
In connection with the separation, certain outstanding DowDuPont stock options were converted into awards of options to purchase shares of the Issuer's common stock. The number of shares and exercise prices of each option award were adjusted in a manner intended to preserve the economic/intrinsic value of the original DowDuPont stock option.
This option is fully vested and exercisable.
13,194 options are vested and exercisable. The remaining options will vest on February 2, 2020.
2,874 options are vested and exercisable. The remaining options will vest in two equal installments on February 15, 2020 and February 15, 2021.
Senior Vice President, Chief Human Resources Officer
/s/Robert Hahm, attorney-in-fact
2019-06-10
EX-24.3_858933
2
poa.txt
POA DOCUMENT
POWER OF ATTORNEY
The undersigned hereby constitutes and appoints each of Cornel Fuerer,
Robert Hahm and Abigail Jarrell, or either of them acting singly and with full
power of
substitution, as the undersigned's true and lawful attorney-in-fact to:
(1) execute for and on behalf of the undersigned, in the
undersigned's
capacity as an officer and/or director of Corteva, Inc. (the
"Company"),
Forms 3, 4, and 5 (and any amendments thereto) in accordance with
Section 16(a) of the Securities Exchange Act of 1934, as amended
the "Exchange Act"), and the rules thereunder;
(2) do and perform any and all acts for and on behalf of the
undersigned that may be necessary or desirable to complete and
execute any such Form 3, 4, or 5, complete and execute any
amendments thereto, and timely file such form with the U.S.
Securities
and Exchange Commission (the "SEC") and any securities exchange or
similar authority, including without limitation the execution and
filing of a Form ID or any other documents necessary or
appropriate
to obtain codes and passwords to enable the undersigned to file
the
Forms 3, 4 and 5 electronically with the SEC; and
(3) take any other action in connection with the foregoing that, in
the opinion of such attorney-in-fact, may be of beneift to, in the
best interest of, or legally required by or for, the undersigned,
it being understood that the documents executed by such attorney-
in-fact on behalf of the undersigned pursuant to this power of
attorney shall be in such form and shall contain such information
and disclosure as such attorney-in-fact may approve in such
attorney-
in-fact's discretion.
The undersigned hereby grants to such attorney-in-fact full power and
authority to do and perform any and every act and thing whatsoever required,
necessary, or proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might
or could do if personally present, with full power of substitution or
revocation, hereby ratifying and confirming all that such attorney-in-fact, or
such attorney-in-fact's substitute or substitutes, shall lawfully do or cause
to be done by virtue of this power of attorney and the rights and powers herein
granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in
serving in such capacity at the request and on behalf of the undersigned, are
not assuming, nor is the Company assuming, any of the undersigned's
responsibilities to comply with any provision of Section 16 of the Exchange
Act.
This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4, and 5 with respect to the
undersigned's holdings of and transactions in securities issued by the Company,
unless earlier revoked by the undersigned in a signed writing delivered to
each
of the foregoing attorneys-in-fact.
IN WITNESS WHEREOF, the undersigned has executed this Power of Attorney
as
of this 17th day of April, 2019.
Signed and acknowledged:
/s/ Meghan Cassidy
--------------------------------------
Meghan Cassidy